Thyroid Nodules Treatment in Edmond

The only definitive way to determine if a thyroid nodule is cancerous is through fine needle aspiration biopsy, but not all nodules require this procedure. We use high-resolution ultrasound to assess features that help predict cancer risk, including irregular borders, microcalcifications, taller-than-wide shape, and increased internal blood flow. Based on these characteristics and nodule size, established guidelines help determine whether biopsy is warranted. The vast majority of thyroid nodules—over 90%—are benign. Even when cancer is detected, most thyroid cancers are highly treatable with excellent long-term outcomes, especially when detected early through appropriate surveillance.

The timeline varies significantly based on your specific situation. Initial evaluation including ultrasound and laboratory testing can typically be completed within 1-2 weeks. If biopsy is needed, results are usually available within another week. Many benign nodules don't require active treatment—only ongoing monitoring with ultrasound every 6-24 months depending on risk factors. If surgery is recommended, scheduling and recovery typically span 4-8 weeks, followed by adjustment of thyroid hormone replacement over 2-3 months. Radioactive iodine treatment for functioning nodules shows response over 3-6 months. Long-term surveillance continues indefinitely with annual or biennial follow-up, but most patients find this minimally disruptive once a stable management pattern is established.

Most thyroid nodules do not require medication or surgery—they can be safely monitored with periodic ultrasound examinations. Surgery is recommended when nodules are confirmed or suspected to be cancerous, cause compressive symptoms like difficulty swallowing or breathing, or are large and cosmetically concerning. Functioning nodules that produce excess thyroid hormone may be treated with antithyroid medications, radioactive iodine ablation, or surgery depending on patient factors and preferences. After thyroid surgery, lifelong thyroid hormone replacement medication is necessary if your entire thyroid is removed, or may be needed if enough thyroid tissue is removed to impair normal function. We thoroughly discuss the risks and benefits of all treatment options to help you make informed decisions aligned with your values and health goals.

Yes, thyroid nodule evaluation and treatment are typically covered medical services under most insurance plans, including Medicare. This includes initial consultation, laboratory testing, thyroid ultrasound, fine needle aspiration biopsy when indicated, and follow-up surveillance imaging. Surgical treatment and radioactive iodine therapy are also covered when medically necessary. Thyroid hormone replacement medication is covered under prescription drug benefits. Coverage specifics vary by plan, and you may have copays, deductibles, or coinsurance responsibilities. We recommend contacting your insurance provider to understand your specific coverage and out-of-pocket costs. Our office can provide documentation of medical necessity and work with your insurance company to facilitate coverage for recommended evaluations and treatments.

Telehealth can be very effective for certain aspects of thyroid nodule care, though hands-on evaluation is necessary at key points. Your initial consultation can often begin virtually, especially if you already have ultrasound or biopsy results to review. Physical examination of the neck is important and requires an in-person visit, as does ultrasound imaging and biopsy procedures. However, follow-up visits to discuss test results, review surveillance imaging, adjust thyroid hormone dosing, and monitor stable nodules can frequently be conducted through secure video visits. This hybrid approach combines the convenience of virtual care with appropriate in-person evaluation, reducing travel burden while maintaining quality. Many patients find that after initial in-person assessment, subsequent monitoring can be managed largely through telehealth with periodic in-person ultrasound examinations.

Changes in thyroid nodules during surveillance warrant reassessment but don't always indicate cancer. Modest growth—typically defined as 20% increase in two dimensions or 50% volume increase—in a previously biopsied benign nodule may prompt repeat biopsy, as sampling error can occasionally occur. Development of new suspicious ultrasound features also triggers additional evaluation. Many benign nodules grow slowly over time without becoming malignant. If a nodule develops compressive symptoms due to size increase, surgical removal may be recommended even if benign. Stable nodules over several years of surveillance can often transition to less frequent monitoring. We carefully track all measurements and characteristics over time, comparing each ultrasound to previous studies to detect clinically significant changes that require action while avoiding unnecessary interventions for minor variations.